India, March 18 -- The shares of the prominent pharmaceutical company gained up to 5 percent in today's trading session after the company entered into definitive agreements for the acquisition and in licensing of a portfolio.

With a market capitalization of Rs 8,485.42 crore, the shares of Strides Pharma Science Ltd were trading at Rs 920.60 per share, increasing around 5 percent as compared to the previous closing price of Rs 876.25 apiece.

Definitive Agreement The shares of Strides Pharma Science Ltd have seen positive movement after its step-down subsidiary, Strides Pharma International AG (SPIAG), executed agreements with Sandoz, the company is set to expand in Sub-Saharan Africa across key markets like Ghana, Nigeria, and Kenya. Wi...